Related Experiment Video
Updated: Jun 18, 2025

Development of Organoids from Mouse Pituitary as In Vitro Model to Explore Pituitary Stem Cell Biology
Published on: February 25, 2022
Developmental pluripotency-associated 4 increases aggressiveness of pituitary neuroendocrine tumors by enhancing cell
Shaista Chaudhary1, Ujjal Das1, Shaima Jabbar2,1
1The Endocrine Program, Department of Animal Sciences, Rutgers, The State University of New Jersey, New Brunswick, New Jersey, USA.
Background:
Pituitary neuroendocrine tumors, PitNETs, are often aggressive and precipitate in distant metastases that are refractory to current therapies. However, the molecular mechanism in PitNETs' aggressiveness is not well understood. Developmental pluripotency-associated 4 (DPPA4) is known as a stem cell regulatory gene and overexpressed in certain cancers, but its function in the context of PitNETs' aggressiveness is not known.
Methods:
We employed both rat and human models of PitNETs. In the rat pituitary tumor model, we used prenatal-alcohol-exposed (PAE) female Fischer rats which developed aggressive PitNETs following estrogen treatment, while in the human pituitary tumor model, we used aggressively proliferative cells from pituitary tumors of patients undergone surgery. Various molecular, cellular, and epigenetic techniques were used to determine the role of DPPA4 in PitNETs' aggressiveness.
Results:
We show that DPPA4 is overexpressed in association with increased cell stemness factors in aggressive PitNETs of PAE rats and of human patients. Gene-editing experiments demonstrate that DPPA4 increases the expression of cell stemness and tumor aggressiveness genes and promotes proliferation, colonization, migration, and tumorigenic potential of PitNET cells. ChIP assays and receptor antagonism studies reveal that DPPA4 binds to canonical WINTs promoters and increases directly or indirectly the WNT/β-CATENIN control of cell stemness, tumor growth, and aggressiveness of PitNETs. Epigenetic studies show the involvement of histone methyltransferase in alcohol activation of DPPA4.
Conclusions:
These findings support a role of DPPA4 in tumor stemness and aggressiveness and provide a preclinical rationale for modulating this stemness regulator for the treatment of PitNETs.
Insights
Developmental pluripotency-associated 4 (DPPA4) drives pituitary tumor stemness and aggressiveness by regulating WNT/β-CATENIN signaling. Targeting DPPA4 offers a potential therapeutic strategy for aggressive pituitary neuroendocrine tumors (PitNETs).
Area of Science:
- Endocrinology
- Cancer Biology
- Molecular Oncology
Background:
- Pituitary neuroendocrine tumors (PitNETs) are often aggressive and metastasize, with limited treatment options.
- The molecular drivers of PitNET aggressiveness remain poorly understood.
- Developmental pluripotency-associated 4 (DPPA4), a stem cell regulator, is overexpressed in some cancers but its role in PitNETs is unknown.
Purpose of the Study:
- To investigate the role of DPPA4 in the aggressiveness of pituitary neuroendocrine tumors (PitNETs).
- To elucidate the molecular mechanisms by which DPPA4 contributes to PitNET stemness and proliferation.
Main Methods:
- Utilized both rat (prenatal-alcohol-exposed) and human pituitary tumor models.
- Employed gene editing, ChIP assays, epigenetic studies, and receptor antagonism.
- Assessed DPPA4 expression and its impact on cell proliferation, migration, and tumorigenic potential.
Main Results:
- DPPA4 is overexpressed in aggressive PitNETs, correlating with increased cell stemness factors.
- DPPA4 promotes PitNET cell proliferation, migration, and tumorigenesis by regulating WNT/β-CATENIN signaling.
- Histone methyltransferase is involved in alcohol-induced activation of DPPA4.
Conclusions:
- DPPA4 plays a significant role in pituitary tumor stemness and aggressiveness.
- Targeting DPPA4 represents a potential therapeutic avenue for aggressive PitNETs.
- Findings provide a preclinical basis for developing DPPA4-modulating therapies.
Related Concept Videos
Induced Pluripotent Stem Cells
Somatic...
Abnormal Proliferation
Somatic to iPS Cell Reprogramming
Maintenance of the ES Cell State
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Source And Potency Of Stem Cells

